AstraZeneca, Amgen's asthma launch Tezspire picks up backing from England's NICE AstraZeneca's chief exec publicly criticized the U.K.'s tax policies last month, but that didn't stop officials there from backing the company's key asthma launch. Log in or register to post comments
